Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G F Savidge

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Prophylaxis versus purse strings: is safety an issue?G F Savidge
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1994
Do safety issues of plasma products constrain self-sufficiency?G F Savidge
Acta Medica Scandinavica|January 1, 1979
Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis. A comparative study between streptokinase and heparin therapyR Watz, G F Savidge
Thrombosis Research|February 1, 1979
An optimized radioimmunoassay of F VIII related antigen (F VIIIR:AG) in plasma and eluatesG F Savidge, G Carlebjörk
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1993
Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitorsG Majumdar, G F Savidge
British Journal of Haematology|March 1, 1988
High-dose intravenous immunoglobulin and splenectomy for the treatment of HIV-related immune thrombocytopenia in patients with severe haemophiliaJ Beard, G F Savidge
Haemostasis|January 1, 1996
NovoSeven (recombinant factor VIIa) in centeral nervous systems bleedsK M Rice, G F Savidge
Transfusion Science|August 5, 1996
Recombinant factor VIIa (r-FVIIa) in haemophilia managementK M Rice, G F Savidge
Bioseparation|January 1, 1991
The interaction of the factor VIII/von Willebrand factor complex (VIII/vWf), with guanidinium-derivatized matricesR H Saundry, G F Savidge
British Journal of Haematology|July 27, 2001
Use of recombinant factor VIIa for post-operative haemorrhage in a patient with Glanzmann's thrombasthenia and human leucocyte antigen antibodiesR K Patel, G F Savidge, S Rangarajan
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Prophylaxis versus purse strings: is safety an issue?G F Savidge
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1994
Do safety issues of plasma products constrain self-sufficiency?G F Savidge
Acta Medica Scandinavica|January 1, 1979
Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis. A comparative study between streptokinase and heparin therapyR Watz, G F Savidge
Thrombosis Research|February 1, 1979
An optimized radioimmunoassay of F VIII related antigen (F VIIIR:AG) in plasma and eluatesG F Savidge, G Carlebjörk
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1993
Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitorsG Majumdar, G F Savidge
British Journal of Haematology|March 1, 1988
High-dose intravenous immunoglobulin and splenectomy for the treatment of HIV-related immune thrombocytopenia in patients with severe haemophiliaJ Beard, G F Savidge
Haemostasis|January 1, 1996
NovoSeven (recombinant factor VIIa) in centeral nervous systems bleedsK M Rice, G F Savidge
Transfusion Science|August 5, 1996
Recombinant factor VIIa (r-FVIIa) in haemophilia managementK M Rice, G F Savidge
Bioseparation|January 1, 1991
The interaction of the factor VIII/von Willebrand factor complex (VIII/vWf), with guanidinium-derivatized matricesR H Saundry, G F Savidge
British Journal of Haematology|July 27, 2001
Use of recombinant factor VIIa for post-operative haemorrhage in a patient with Glanzmann's thrombasthenia and human leucocyte antigen antibodiesR K Patel, G F Savidge, S Rangarajan
Pageof 9